HIF1A and cancer: Both HIF-1α and Stat3 promote aerobic glycolysis and downregulate oxidative phosphorylation in cancer cells [48], suggesting that GRIM-19 may downregulate aerobic glycolysis by reducing HIF-1α and Stat3 levels and activities.